SEC Info - CollPlant Biotechnologies Ltd.

SEC Info℠

Home

Help

Please Sign In

CollPlant Biotechnologies Ltd. – ‘6-K’ for 8/26/22

On: Friday, 8/26/22, at 8:58am ET · For: 8/26/22 · Accession #: 1213900-22-51242 · File #: 1-38370

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/26/22  CollPlant Biotechnologies Ltd.    6-K         8/26/22    2:4.5M                                   EdgarAgents LLC/FA

Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K — SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Report of Foreign Private Issuer                    HTML      9K 
 2: EX-99.1     Corporate Presentation                              HTML     28K

‘6-K’ — Report of Foreign Private Issuer

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2022

Commission File Number 001-38370

CollPlant Biotechnologies Ltd.

(Exact name of registrant as specified in its charter)

4 Oppenheimer St, Weizmann Science Park

Rehovot 7670104, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐

CollPlant Biotechnologies Ltd. has posted to its website an updated corporate presentation. A copy of the presentation is furnished with this Report of Foreign Private Issuer on Form 6-K as Exhibit 99.1 and is incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	COLLPLANT BIOTECHNOLOGIES LTD.

Date: August 26, 2022	By:	/s/ *Eran Rotem*
		Name: Eran Rotem
		Title: Deputy CEO and Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘6-K’ Filing	Date	Other Filings

Filed on / For Period end:	8/26/22	None on these Dates
		List all Filings

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/30/22  CollPlant Biotechnologies Ltd.    F-3                    6:415K                                   EdgarAgents LLC/FA

↑Top

Filing Submission 0001213900-22-051242 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)